Follicum is a pharmaceutical company. The greatest focus is on the development of drug candidates that stimulate hair growth in patients. Currently products are held that may stimulate hair growth, but also hamper the degree of hair growth, mainly derived from hirsutism, which implicates unusually large production of hair in women. The pharmaceutical consists of endogenous, human proteins, which influence the processing of hair follicles. The company was established in 2011 and is based in Lund.

Quotes for Follicum AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Jonas Edelswärd (tf)

Chairperson of the Board

  • Gun-Britt Fransson

Board

  • Alejandra Mørk
  • Carl-Johan Spak
  • Lars H. Bruzelius

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 8,65 8,65 2021-12-31
Recipharm Venture Fund AB 5,34 5,34 2021-12-31
Mats Paulssons Stiftelse För Forskning Innovation Samhällsbygg 3,92 3,92 2021-12-31
Brushamn Invest AB 3,42 3,42 2021-12-31
Tibia Konsult AB 3,38 3,38 2021-12-31
Mats Lundberg 2,67 2,67 2021-12-31
Erik Fällström via bolag 2,45 2,45 2020-12-31
Dan Peters 2,45 2,45 2021-12-31
Nordnet Pensionsförsäkring 2,20 2,20 2021-12-31
Pia Althin 2,02 2,02 2021-12-31

Insider trading